Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

1.16
0.0000
Post-market: 1.170.0100+0.86%19:21 EDT
Volume:84.35K
Turnover:96.95K
Market Cap:4.50M
PE:-0.12
High:1.17
Open:1.17
Low:1.12
Close:1.16
52wk High:24.30
52wk Low:1.03
Shares:3.88M
Float Shares:3.81M
Volume Ratio:0.35
T/O Rate:2.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.16
PE(LYR):-0.08

Loading ...

Sunshine Biopharma Wins Canadian Approval for Generic Enalapril Tablets

Reuters
·
Aug 19

Sunshine Biopharma: Enalapril Expected to Begin Shipping to Canadian Pharmacies by Year-End 2026

THOMSON REUTERS
·
Aug 19

Sunshine Biopharma: Receives Canadian Regulatory Approval for Enalapril

THOMSON REUTERS
·
Aug 19

Sunshine Biopharma Q2 Net Loss Narrows 11.67% to $1.56 Million; Revenue Slips 1.6% to $9.26 Million

Reuters
·
Aug 14

Sunshine announces approval of generic Dienogest tablets for Canadian market

TIPRANKS
·
Aug 04

Sunshine Biopharma Cuts Exercise Price of Outstanding Series B Warrants to $1.22

Reuters
·
Aug 03

Sunshine Biopharma Receives Health Canada Approval for Generic Ondansetron to Treat Chemotherapy-Induced Nausea

MT Newswires Live
·
Jul 28

Sunshine Biopharma announces approval of generic Ondansetron tablets

TIPRANKS
·
Jul 28

Sunshine Biopharma - Enters At-the-market Sales Agreement with Aegis Capital for up to $4 Mln - SEC Filing

THOMSON REUTERS
·
Jul 21

Sunshine Biopharma Plans up to $4 Million At-the-market Share Sale Via Aegis Capital

Reuters
·
Jul 21

Sunshine Biopharma announces publication of new results on MR1-114

TIPRANKS
·
Jul 20

Sunshine Biopharma Says Study Shows Mr1-114 Sars-cov-2 Inhibitor Effective in Mice, Potent in Vitro Across Variants

Reuters
·
Jul 20

Sunshine Biopharma Announces Release of Research Findings Press Statement

Reuters
·
Jul 20

Sunshine Biopharma Settles Dispute with Former Nora Pharma President for CAD 1.5 Million

Reuters
·
Jul 11

Sunshine Biopharma Wins Canadian Approval for Generic Arimidex Tablet

Reuters
·
Jun 25

Sunshine Biopharma shareholders OK Nasdaq-related approval provisions for Series C warrants from $6 million offering

Reuters
·
Jun 09

Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets

Reuters
·
Jun 01

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM

Reuters
·
Jun 01

NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

Reuters
·
May 30

Sunshine Biopharma Inc trading halted, news pending

TIPRANKS
·
May 30